Kwan Suk Jo; Nam Cho Kim

doi:10.4040/jkan.2014.44.5.542

Articles

Page Path: HOME > J Korean Acad Nurs > Volume 44(5); 2014 > Article

Original Article
Incidence and Factors Influencing Oral Mucositis in Patients with Hematopoietic Stem Cell Transplantation: Kwan Suk Jo, Nam Cho Kim; Journal of Korean Academy of Nursing 2014;44(5):542-551.
DOI: https://doi.org/10.4040/jkan.2014.44.5.542
Published online: October 31, 2014

¹Graduate School, The Catholic University of Korea, Seoul, Korea.

²College of Nursing, The Catholic University of Korea, Seoul, Korea.

Address reprint requests to: Kim, Nam Cho. College of Nursing, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea. Tel: +82-2-2258-7405, Fax: +82-2-2258-7772, kncpjo@catholic.ac.kr

• Received: May 9, 2014 • Revised: May 23, 2014 • Accepted: August 21, 2014

This is an Open Access article distributed under the terms of the Creative Commons Attribution NoDerivs License. (http://creativecommons.org/licenses/by-nd/4.0/) If the original work is properly cited and retained without any modification or reproduction, it can be used and re-distributed in any format and medium.

10 Views
0 Download
5 Scopus

prev next

Full Article

Download PDF

Abstract
NOTES
REFERENCES

Abstract

Purpose
This study was done to examine the incidence of oral mucositis in hematopoietic stem cell transplantation patients and to identify factors influencing oral mucositis and patient outcomes according to severity.
Methods
In this retrospective study, data were collected from electronic medical records of 222 patients who had received hematopoietic stem cell transplantation. Oral mucositis was evaluated using WHO's assessment scale. Data were analyzed using Chi-square test, Fisher exact test, Spearman's correlation, Ordinal logistic regression, ANOVA and Kruskal-Wallis test.
Results
A total of 69.8% of the patients evaluated developed oral mucositis (grade II and over). As a results of ordinal regression, factors influencing oral mucositis severity were found to be diagnosis, type of transplantation, oxygen inhalation and the number of antiemetics administration before transplantation. The severity of oral mucositis was found to increase the days of hospitalization, days of TPN administration, days of using antibiotics and the number and dosage of analgesics.
Conclusion
The results would help predict severity of oral mucositis in hematopoietic stem cell transplantation patients and suggest that provision of appropriate nursing assessment and oral care would improve patient outcomes.
Keywords: Hematopoietic stem cells; Transplantation; Mucositis

This study was supported by the College of Nursing, The Catholic University of Korea in 2014.

REFERENCES

1. Larsen J, Nordstrom G, Ljungman P, Gardulf A. Symptom occurrence, symptom intensity, and symptom distress in patients undergoing highdose chemotherapy with stem-cell transplantation. Cancer Nurs. 2004;27(1):55–64.Article PubMed
2. Hernández-Fernández A, Oñate-Sánchez RE, Cabrerizo-Merino MC, de Arriba-de la-Fuente F, Heras-Fernando I, Vicente-Garcia V. Influence of oral health on mucositis in patients undergoing hematopoietic progenitor cell transplantation (HPCT). Med Oral Patol Oral Cir Bucal. 2012;17(1):e94–e101.PubMed
3. Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, et al. Emerging evidence on the pathobiology of mucositis. Support Care Cancer. 2013;21(11):3233–3241. http://dx.doi.org/10.1007/s00520-013-1900-xArticle PubMed PDF
4. Niscola P, Romani C, Cupelli L, Scaramucci L, Tendas A, Dentamaro T, et al. Mucositis in patients with hematologic malignancies: An overview. Haematologica. 2007;92(2):222–231.Article PubMed
5. Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ. Patient reports of complications of bone marrow transplantation. Support Care Cancer. 2000;8(1):33–39.Article PubMed PDF
6. Eilers J, Million R. Clinical update: Prevention and management of oral mucositis in patients with cancer. Semin Oncol Nurs. 2011;27(4):e1–e16. http://dx.doi.org/10.1016/j.soncn.2011.08.001Article
7. Sonis ST. Mucositis: The impact, biology and therapeutic opportunities of oral mucositis. Oral Oncol. 2009;45(12):1015–1020. http://dx.doi.org/10.1016/j.oraloncology.2009.08.006Article PubMed
8. Vera-Llonch M, Oster G, Ford CM, Lu J, Sonis S. Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Support Care Cancer. 2007;15(5):491–496. http://dx.doi.org/10.1007/s00520-006-0176-9Article PubMed PDF
9. Gabriel DA, Shea T, Olajida O, Serody JS, Comeau T. The effect of oral mucositis on morbidity and mortality in bone marrow transplant. Semin Oncol. 2003;30:6 Suppl 18. 76–83.Article PubMed
10. Kashiwazaki H, Matsushita T, Sugita J, Shigematsu A, Kasashi K, Yamazaki Y, et al. A comparison of oral mucositis in allogeneic hematopoietic stem cell transplantation between conventional and reduced-intensity regimens. Support Care Cancer. 2012;20(5):933–939. http://dx.doi.org/10.1007/s00520-011-1164-2Article PubMed PDF
11. Eilers J. Nursing interventions and supportive care for the prevention and treatment of oral mucositis associated with cancer treatment. Oncol Nurs Forum. 2004;31:4 Suppl. 13–23. http://dx.doi.org/10.1188/04.onf.s4.13-23Article
12. Ohbayashi Y, Imataki O, Ohnishi H, Iwasaki A, Ogawa T, Inagaki N, et al. Multivariate analysis of factors influencing oral mucositis in allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2008;87(10):837–845. http://dx.doi.org/10.1007/s00277-008-0508-6Article PDF
13. Cheng KK, Lee V, Li CH, Goggins W, Thompson DR, Yuen HL, et al. Incidence and risk factors of oral mucositis in paediatric and adolescent patients undergoing chemotherapy. Oral Oncol. 2011;47(3):153–162. http://dx.doi.org/10.1016/j.oraloncology.2010.11.019Article
14. Vokurka S, Bystricka E, Scudlova J, Mazur E, Visokaiova M, Vasilieva E, et al. The risk factors for oral mucositis and the effect of cryotherapy in patients after the BEAM and HD-l-PAM 200 mg/m(2) autologous hematopoietic stem cell transplantation. Eur J Oncol Nurs. 2011;15(5):508–512. http://dx.doi.org/10.1016/j.ejon.2011.01.006Article PubMed
15. Park MH, Park JS. Difference of oral mucositis in hospitalized cancer patients receiving chemotherapy. Asian Oncol Nurs. 2013;13(2):76–84. http://dx.doi.org/10.5388/aon.2013.13.2.76Article PDF
16. Son YJ, Shin YJ, Cho MY, Kim SH, Park OS, Han SY, et al. The development of an oral care protocol for cancer patients receiving chemotherapy and its effects. J Korean Clin Nurs Res. 2011;17(1):113–122.
17. Song CE, So HS, Ju D, Kim EJ. Randomized controlled trial for preventing stomatitis and discomfort among acute leukemic patients. J Korean Oncol Nurs. 2011;11(1):33–40. http://dx.doi.org/10.5388/jkon.2011.11.1.33Article PDF
18. Choi SE, Kim HS. Sodium bicarbonate solution versus chlorhexidine mouthwash in oral care of acute leukemia patients undergoing induction chemotherapy: A randomized controlled trial. Asian Nurs Res. 2012;6(2):60–66.Article
19. Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol. 2001;19(8):2201–2205.Article PubMed
20. Niscola P. Mucositis in malignant hematology. Expert Rev Hematol. 2010;3(1):57–65. http://dx.doi.org/10.1586/ehm.09.71Article PubMed
21. Strobel ES, Bauchmuller K, Ihorst G, Engelhardt M. Frequency, severity and risk factors for oral mucositis after BEAM conditioning and autologous peripheral blood stem cell transplantation: A single center analysis and review of the literature. Leuk Lymphoma. 2007;48(11):2255–2260. http://dx.doi.org/10.1080/10428190701636492Article PubMed
22. Cheng KK. Association of plasma methotrexate, neutropenia, hepatic dysfunction, nausea/vomiting and oral mucositis in children with cancer. Eur J Cancer Care (Engl). 2008;17(3):306–311. http://dx.doi.org/10.1111/j.1365-2354.2007.00843.xArticle
23. Vagliano L, Feraut C, Gobetto G, Trunfio A, Errico A, Campani V, et al. Incidence and severity of oral mucositis in patients undergoing haematopoietic SCT-results of a multicentre study. Bone Marrow Transplant. 2011;46(5):727–732. http://dx.doi.org/10.1038/bmt.2010.184Article PubMed PDF
24. Barasch A, Peterson DE. Risk factors for ulcerative oral mucositis in cancer patients: Unanswered questions. Oral Oncol. 2003;39(2):91–100.Article PubMed
25. Wardley AM, Jayson GC, Swindell R, Morgenstern GR, Chang J, Bloor R, et al. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. Br J Haematol. 2000;110(2):292–299.Article PDF
26. Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patients who have cancer. Dent Clin North Am. 2008;52(1):61–77. http://dx.doi.org/10.1016/j.cden.2007.10.002Article PubMed PMC
27. Bolwell BJ, Kalaycio M, Sobecks R, Andresen S, Kuczkowski E, Bernhard L, et al. A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantation. Bone Marrow Transplant. 2002;30(9):587–591. http://dx.doi.org/10.1038/sj.bmt.1703694Article PubMed PDF
28. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, et al. Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004;100:9 Suppl. 1995–2025. http://dx.doi.org/10.1002/cncr.20162Article PubMed
29. Robien K, Schubert MM, Bruemmer B, Lloid ME, Potter JD, Ulrich CM. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. J Clin Oncol. 2004;22(7):1268–1275. http://dx.doi.org/10.1200/jco.2004.05.147Article
30. Saunders DP, Epstein JB, Elad S, Allemano J, Bossi P, van de Wetering MD, et al. Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21(11):3191–3207. http://dx.doi.org/10.1007/s00520-013-1871-yArticle PubMed PDF

Table 1

Incidence of Oral Mucositis by Patients Characteristics (N=222)

^*p<.05; ^†Fisher exact test; AML=Acute myeloid leukemia; ALL=Acute lympnoblastic leukemia; MM=Multiple myeloma; SAA=Severe aplastic anemia; MDS=Myelodysplatsic syndrome; MAC=Myeloablative chemotherapy; RIST=Reduced instensified therapy; MPLV=Melphalan based chemotherapy; BMT=Busulfan-melphalan-thiothepa; TAM=Total body irradiation-cytoarabine-melphalan; HSCT=Hematopoietic stem cell transplantation; FMT=Familiar mismatched; CR=Complete remission; IR=Incomplete remission; SS/CP=Stable state/Chronic phase; TBI=Total body irradiation.

Table 2

Correlations of related Variables with Oral Mucositis Grade (N=222)

^*p<.05; HSCT=Hematopoietic stem cell transplantation; BMI=Body mass index; TBI=Total body irradatin.

Table 3

Factors Affecting Grade of Oral Mucositis by Ordinal Logistic Regression (N=222)

^*p<.05; ALL=Acute lymphoblastic leukemia; AML=Acute myeloid leukemia; MDS=Myelodysplatsic syndrome; MM=Multiple myeloma; SAA=Severe aplastic anemia; FMT=Familiar mismatched; IR=Incomplete remission; CR=Complete remission; TBI=Total body irradiation; HSCT=Hematopoietic stem cell transplantation.

Table 4

Patient Outcomes of HSCT Patients by Oral Mucositis Grade (N=222)

^*p<.05; ^†Kruskal-Wallis test; HSCT=Hematopoietic stem cell transplantation; NPO=Nothing per oral; TPN=Total parenteral nutrition.

Figure & Data

REFERENCES

Citations

Citations to this article as recorded by

Cite

CITE: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Incidence and Factors Influencing Oral Mucositis in Patients with Hematopoietic Stem Cell Transplantation

J Korean Acad Nurs. 2014;44(5):542-551. Published online October 31, 2014

DOI: https://doi.org/10.4040/jkan.2014.44.5.542

XML Download

We recommend

Incidence and Factors Influencing Oral Mucositis in Patients with Hematopoietic Stem Cell Transplantation

Table 1

Incidence of Oral Mucositis by Patients Characteristics (N=222)

Table 2

Correlations of related Variables with Oral Mucositis Grade (N=222)

^*p<.05; HSCT=Hematopoietic stem cell transplantation; BMI=Body mass index; TBI=Total body irradatin.

Table 3

Factors Affecting Grade of Oral Mucositis by Ordinal Logistic Regression (N=222)

Table 4

Patient Outcomes of HSCT Patients by Oral Mucositis Grade (N=222)

^*p<.05; ^†Kruskal-Wallis test; HSCT=Hematopoietic stem cell transplantation; NPO=Nothing per oral; TPN=Total parenteral nutrition.

Table 1 Incidence of Oral Mucositis by Patients Characteristics (N=222)

Table 2 Correlations of related Variables with Oral Mucositis Grade (N=222)

^*p<.05; HSCT=Hematopoietic stem cell transplantation; BMI=Body mass index; TBI=Total body irradatin.

Table 3 Factors Affecting Grade of Oral Mucositis by Ordinal Logistic Regression (N=222)

Table 4 Patient Outcomes of HSCT Patients by Oral Mucositis Grade (N=222)

^*p<.05; ^†Kruskal-Wallis test; HSCT=Hematopoietic stem cell transplantation; NPO=Nothing per oral; TPN=Total parenteral nutrition.